Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants.
Hauptmann
J
J
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, Germany.
Markwardt
F
F
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D015195:Drug Design; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D013917:Thrombin